Intrinsic Therapeutics lands $11.6M in new funding for treatment of herniated lumbar discs

Intrinsic draws up $11.6M funding round (MassHighTech)
Spinal implant maker Intrinsic Therapeutics Inc. has landed another round of equity, options and warrants financing, according to documents filed with the U.S. Securities and Exchange Commission.
The Woburn company behind the Barracaid spinal implant used as treatment for herniated lumbar discs received $11.6 million of a $20 million offering. A total of 11 investors participated in the offering as of October 26.
Along with newly appointed CEO Cary Hagan, listed on the filing as directors are Ryan Drant and Josh Makower of New Enterprise A...